UroGen Pharma shows strong growth with RTGel technology, FDA approvals for JELMYTO and ZUSDURI, and accelerating 2026 revenue outlook. See why URGN stock is a buy.
After leading the Irish to the 2022 state title game, hometown hero Brock Thomas has beat the odds to earn a spot on the Ducks' two-deep.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback